Acute Myeloid Leukemia (AML)

People with mutated acute myeloid leukemia (AML) are asked to participate in a research study being conducted by the Montefiore Medical Center.

You may be eligible to participate in this study if you:

• Are considered an adult according to local regulation at the time of obtaining informed consent
• Have a diagnosis of previously untreated AML according to World Health Organization

You may not participate in this study if you:

• Have active, symptomatic CNS involvement with AML
• Have previously treated with CAR-T cell therapy for AML or MDS
• Are receiving treatment with any other investigational agents
• Have had major surgery within 4 weeks prior to the first study dose
• Are pregnant or breast-feeding women

Contact Information
Joel Victor, Study Coordinator
Phone: (718) 920-6680